CD27 and cancer: In particular, the use of monoclonal antibodies—including Varliumab (anti-human CD27)—in cancer treatment has been studied in multiple clinical trials, but the anti-CD27 mAb has been produced only in CHO cells, and contamination and high cost are concerns when using CHO cells (Nosaki et al., 2021a).